Chakma Justin 4
4 · ARS Pharmaceuticals, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Chakma Justin
Chief Business Officer
Transactions
- Award
Stock option (right to buy)
2025-01-02+274,100→ 274,100 totalExercise: $10.71Exp: 2035-01-01→ Common Stock (274,100 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025.